Generic cystic fibrosis drug from Bangladesh costs a fraction of US price
A generic version of a breakthrough cystic fibrosis drug, manufactured in Bangladesh, is reaching patients around the world at a fraction of the price charged in the United States. A legal loophole has enabled the production and distribution of this cheaper alternative, offering a potential lifeline to families who cannot afford the original medication. The development could significantly expand access to a treatment previously out of reach for many.
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!